======= WDR91 ======= == Gene Information == * **Official Symbol**: WDR91 * **Official Name**: WD repeat domain 91 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29062|29062]] * **UniProt**: [[https://www.uniprot.org/uniprot/A4D1P6|A4D1P6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WDR91&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WDR91|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616303|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport (PubMed:26783301). It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradation by the lysosome (PubMed:27126989). May play a role in meiosis (By similarity). {ECO:0000250|UniProtKB:Q7TMQ7, ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:27126989}. No Pfam Domain information is available for this gene. |phosphatidylinositol 3-kinase regulator activity| |extrinsic component of endosome membrane| |early endosome to late endosome transport| |vesicle-mediated transport between endosomal compartments| |regulation of phosphatidylinositol 3-kinase activity| |regulation of lipid kinase activity| |regulation of phospholipid metabolic process| |late endosome membrane| |cytosolic transport| |early endosome membrane| |regulation of cellular protein catabolic process| |regulation of protein catabolic process| |regulation of lipid metabolic process| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |regulation of cellular catabolic process| |regulation of kinase activity| |cellular macromolecule catabolic process| |regulation of transferase activity| |regulation of catabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |proteolysis| |intracellular transport| |regulation of phosphorylation| |organic substance catabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |establishment of localization in cell| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.22| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.98| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|1.98| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3990 * **Expression level (log2 read counts)**: 5.09 {{:chemogenomics:nalm6 dist.png?nolink |}}